Takashi Ogura   Hiroyuki Taniguchi   Arata Azuma   Yoshikazu Inoue   Yasuhiro Kondoh   Yoshinori Hasegawa   Masashi Bando   Shinji Abe   Yoshiro Mochizuki   Kingo Chida   Matthias Klueglich   Tsuyoshi Fujimoto   Kotaro Okazaki   Yusuke Tadayasu   Wataru Sakamoto   Yukihiko Sugiyama   
EUROPEAN RESPIRATORY JOURNAL 45(5) 1382-1392 2015年5月 [査読有り]
A randomised, double-blind, phase II, dose escalation trial was conducted to assess the safety, tolerability and pharmacokinetics of the tyrosine kinase inhibitor nintedanib, alone and when added to ongoing pirfenidone therapy, in Japanese patient...